Last updated on November 2019

Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Multiple Myeloma
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 18 years or older at the time of carfilzomib initiation
  • At least one prior line of MM treatment has been received
  • Carfilzomib treatment has been initiated per routine practice and is currently ongoing
  • At least one administration of carfilzomib in a combination regimen (ie, not monotherapy) has been received
  • Provided written informed consent prior to abstraction of any data, in countries where written informed consent is required.
  • Subjects who previously completed treatment with carfilzomib in a clinical trial, a compassionate use program or through routine practice, are eligible to take part in the study.
  • Subjects who receive radiotherapy concurrently with carfilzomib treatment are also eligible to take part in the study.
  • Subjects who initiate carfilzomib treatment on a combination regimen, subsequently discontinue all concomitant medications but remain on carfilzomib monotherapy in later cycles, remain eligible for participation in the study.
  • Subjects who are also enrolled in other observational studies in which standard of care is not altered are eligible to take part in the study,

Exclusion Criteria:

  • Subjects who are enrolled in a carfilzomib clinical trial will not be eligible to additionally take part in this observational study.
  • Subjects who are receiving carfilzomib treatment within a compassionate use program will not be eligible to take part in this observational study. If a subject who has enrolled into this observational study, also enrolls in a clinical trial in which MM treatment and/or disease management is protocol-specified, the subject becomes ineligible and the subject's data will be censored from the time the subject enrolled the clinical trial.

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.